Live Breaking News & Updates on உலகளாவிய ப்ராஜெக்ட் தலை

Stay updated with breaking news from உலகளாவிய ப்ராஜெக்ட் தலை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Axcella Announces Alison D. Schecter, M.D., as President of R&D


Experienced biopharma leader to oversee research, candidate development, clinical and regulatory functions
CAMBRIDGE, Mass. (BUSINESS WIRE) Axcella (Nasdaq:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced the appointment of Alison D. Schecter, M.D., as the company’s President of Research and Development. In this role, Dr. Schecter will oversee all of the company’s research, product candidate design, clinical and regulatory efforts. Additionally, Manu Chakravarthy, M.D., Ph.D., has decided to step down as the company’s Chief Medical Officer to pursue another opportunity. ....

United Kingdom , United States , Alisond Schecter , Icahn School Of Medicine At Mount Sinai , Downstate Health Sciences University , Selecta Biosciences Inc , Global Program Head At Baxalta , Novartis Institutes Of Biomedical Research , Jj Innovation Center , Cardiovascular Research Institute , Manu Chakravarthy , Chief Medical Officer , Bill Hinshaw , Chief Executive Officer , Selecta Biosciences , Global Project Head , Rare Diseases , Global Program Head , Northeastjj Innovation Center , Novartis Institutes , Biomedical Research , Associate Professor , Icahn School , Internal Medicine , Johns Hopkins Hospital , Massachusetts General Hospital ,